ITGAM and neoplasm: Low-dose antineoplastic agents such as CPA and 5-Fu increase immunosuppressive proangiogenic Gr-1+CD11b+ BMDC levels, suggesting that they could promote tumor growth through the dual mechanism of enhancing angiogenesis and inhibiting immune function.